{"TopicDetails": {"type": 0, "ccm2Id": 31065387, "cftId": 0, "identifier": "IMI2-2015-03-02", "title": "Assessing Risk and Progression of Prediabetes and Type 2 Diabetes to Enable Disease Modification", "publicationDateLong": 1418774400000, "callIdentifier": "H2020-JTI-IMI2-2015-03-two-stage", "callTitle": "IMI2 3rd Call for Proposals", "callccm2Id": 31067006, "allowPartnerSearch": true, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31062059, "abbreviation": "EU.3.1.7.", "description": "Innovative Medicines Initiative 2 (IMI2)"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}, {"id": 31062065, "abbreviation": "EU.3.1.7.6.", "description": "Psychiatric diseases"}], "topicMGAs": [], "keywords": ["Mental health", "Dementia", "Clinical Trials", "Clinical targets", "Patient stratification", "Taxonomy", "Co-morbidity", "Neurological disorders (e.g. Alzheimer's disease,", "Mental disorders", "Psychiatric disorders", "Human biology", "Molecular and cellular neuroscience", "Clinical data", "Applied biology", "Neurodegenerative disorders", "Systems biology", "Clinical information", "Neurochemistry and neuropharmacology", "Translational medicine", "Higher brain functions"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "17 December 2014", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["24 March 2015", "29 September 2015"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3206648": [{"action": "IMI2-2015-03-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-06 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-05 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["0"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Specific Challenge Current therapies for type 2 diabetes focus on the control of blood glucose levels rather than the modification of the disease.\u00a0 Therefore more robust delineation of clinical risk factors, phenotypes, and molecular biomarkers is needed to identify individuals at risk of rapid progression from prediabetes to type 2 diabetes for disease prevention therapeutic intervention trials.\u00a0 More intensive phenotyping of individuals with type 2 diabetes is needed to characterize rates of disease progression and to identify and validate biomarkers and/or indicators of \u201crapid failure\u201d of insulin-producing pancreatic beta cells and of cellular targets of insulin-mediated glucose disposition, including hepatocytes, skeletal muscle, and adipocytes.\u00a0 Validation of robust markers of type 2 diabetes disease progression would facilitate patient segmentation for feasible assessments of new therapeutic options for disease modification Scope </p><p>The overall aim of the project is to discover and validate a molecular taxonomy of type 2 diabetes to enable feasible patient segmentation, clinical trial design, and regulatory paths for diabetes prevention and for modification of diabetes disease progression.</p><p> Expected Impact </p><p>Project is expected to discover and validate human phenotypes and biomarker panels for patient segmentation/selection, clinical trial design and regulatory paths to assess new therapeutic options for prevention of type 2 diabetes as well as slowing down the progression of the disease.</p><p>In addition new regulatory approaches or standards enabling innovative and feasible clinical trial designs for disease modification in patients with prediabetes or type 2 diabetes will be developed. As well as benefit/risk models for public health and economic impact of those interventions.</p><p> Budget </p><p>IMI contribution:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EUR 8 130 000</p><p>EFPIA contribution:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EUR 8 130 000</p><p>Total: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EUR 16 260 000</p>\n", "conditions": "<p>Please read the <strong>IMI2 3rd Call Topics Text</strong> for full details of this topic, including the budget breakdown.<br />\r\nPlease note that submitting proposals for this call can only be done through the<strong> IMI SOFIA software tool</strong>.</p>\r\n<p>Please read carefully all provisions below before the preparation of your application.</p>\r\n<ol>\r\n    <li><strong>List of countries and applicable rules for funding:</strong><br />\r\n    described in <strong>article 10(2) of Regulation N&deg; 1290/2013 of 11 December 2013</strong> laying down the rules for participation and dissemination in Horizon 2020 and in article 1 of the <strong>Commission Delegated Regulation (EU) N&deg; 622/2014 of 14 February 2014<br />\r\n    </strong></li>\r\n    <li><strong>Eligibility and admissibility conditions:</strong><br />\r\n    described in the<strong> IMI2 Manual for evaluation, submission and grant award</strong>. See also the <strong>Commission Delegated Regulation (EU) N&deg; 622/2014 of 14 February 2014<br />\r\n    </strong></li>\r\n    <li><strong>Evaluation</strong><br />\r\n    Guide to the submission and evaluation process including evaluation criteria and procedure, scoring and threshold:<br />\r\n    described in the <strong>IMI2 Manual for submission, evaluation and grant award</strong>.<br />\r\n    See also the proposal templates for your specific action in section 6, below.<br />\r\n    &nbsp;</li>\r\n    <li><strong>Proposal page limits and layout:</strong><br />\r\n    Please refer to the proposal templates for your specific action, see section 6, below.<br />\r\n    &nbsp;</li>\r\n    <li><strong>Indicative timetable for evaluation and grant agreement:</strong><br />\r\n    Notification of outcomes of Stage 1 evaluations: Maximum 5 months from deadline for submitting proposals<br />\r\n    Notification of outcomes of Stage2 evaluations: Maximum 5 months from deadline for submitting full proposals<br />\r\n    Signature of grant agreements: maximum 3 months from the date of informing successful applicants.<br />\r\n    &nbsp;</li>\r\n    <li><strong>Provisions, proposal templates and evaluation forms</strong><br />\r\n    <strong>IMI2 Model Grant Agreement<br />\r\n    Summary of the most relevant provisions for participating in IMI2 actions<br />\r\n    IMI2 RIA/IA Proposal template<br />\r\n    IMI2 RIA/IA Evaluation form<br />\r\n    Template for essential clinical trial information</strong></li>\r\n</ol>\r\n<p><br />\r\n&nbsp;</p>", "supportInfo": "<div>\r\n<p>Contact the <strong>IMI Programme Office</strong>. E-mail: <a href=\"mailto:Infodesk@imi.europa.eu\"><strong>Infodesk@imi.europa.eu</strong></a>&nbsp;&nbsp;Tel.: +32 2 221 8181</p>\r\n<p><a href=\"mailto:sofia@imi.europa.eu\"><strong>IT Helpdesk</strong></a> - contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p>\r\n<p><a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><strong>IMI2 States Representative Group (SRG)</strong></a>&nbsp;- contact your SRG&nbsp;member for assistance</p>\r\n<p><span><a href=\"http://www.imi.europa.eu/content/partner-search\"><strong>IMI Partner Search Tool</strong></a> helps you find a partner organisation for your proposal</span></p>\r\n<p><span><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/support/national_contact_points.html\"><strong>National Contact Points (NCP)</strong></a></span></p>\r\n<p><span><a href=\"http://een.ec.europa.eu/\"><strong>Enterprise Europe Network</strong></a> &ndash; national contact points' advice to businesses with focus on SMEs. The support includes guidance on the EU research funding.</span></p>\r\n<p><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\"><strong>Research Enquiry Service</strong></a> &ndash; ask questions about any aspect of European research and EU R&amp;I programmes</p>\r\n<p><strong>Ethics</strong> &ndash; for compliance with ethical issues, see the <a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\">Participant Portal</a>&nbsp;and&nbsp;<a href=\"http://ec.europa.eu/research/science-society/index.cfm?fuseaction=public.topic&amp;id=1289&amp;lang=1\">Science and Society Portal</a></p>\r\n<p><a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><strong>The European Charter for Researchers and the Code of Conduct for their recruitment</strong></a></p>\r\n<p><a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\">research@cencenelec.eu</a>.</p>\r\n</div>", "sepTemplate": "<p>To access the Electronic Submission Service of the topic, please select the <strong>type of action</strong> that is most relevant to your proposal from the list below and click on the <strong>'Start Submission' </strong>button. You will then be asked to confirm your choice of the type of action, the topic for the call, as these cannot be changed subsequently in the submission system. Upon confirmation you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Participant Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2015-03-two-stage", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA-IA", "criterionDescription": "(Research and) Innovation action", "url": "https://sofia.imi.europa.eu/", "startDate": "Jan 15, 2015 5:35:00 PM"}], "additionalDossiers": [], "infoPackDossiers": [{"callId": 6770, "id": 7783, "title": "IMI2 Call 3 Text", "sectionId": 6770, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 870711, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-02/1635145-imi2_call-3_text_en.pdf", "id": 1635145, "fileName": "IMI2_Call-3_Text_en.pdf", "common": false, "crc32": 4035280651}]}, {"callId": 6770, "id": 7788, "title": "IMI2 Call 3 - General Conditions", "sectionId": 6770, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 224364, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-02/1635141-generalconditionsforthecall_en.pdf", "id": 1635141, "fileName": "GeneralConditionsfortheCall_en.pdf", "common": false, "crc32": 993791134}]}, {"callId": 6770, "id": 7773, "title": "Summary of the most relevant provisions for participating in IMI2 actions", "sectionId": 6770, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 177193, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-02/1635134-imi2_summary_of_most_relevant_provisions_for_participating_in_imi2_actions_en.pdf", "id": 1635134, "fileName": "IMI2_Summary of most relevant provisions for participating in IMI2 actions_en.pdf", "common": false, "crc32": 1929684055}]}, {"callId": 6770, "id": 7768, "title": "IMI2 Manual for Submission, Evaluation, and Grant Award", "sectionId": 6770, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 546419, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-02/1635132-imi2_manual_for_submission_evaluation_grant_award_en.pdf", "id": 1635132, "fileName": "IMI2_Manual_for_submission_evaluation_grant award_en.pdf", "common": false, "crc32": 1572805413}]}, {"callId": 6770, "id": 7758, "title": "IMI2 RIA/IA Proposal Template (doc)", "sectionId": 6770, "translationFiles": [{"language": "en", "mimeType": "application/msword", "fileSize": 599040, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-02/1635129-imi2_proposal-template_ria-ia_en.doc", "id": 1635129, "fileName": "IMI2_Proposal-Template_RIA-IA_en.doc", "common": false, "crc32": 1032474637}]}, {"callId": 6770, "id": 7753, "title": "IMI2 RIA/IA Proposal Template (pdf)", "sectionId": 6770, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 194840, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-02/1635128-imi2_proposal-template_ria-ia_en.pdf", "id": 1635128, "fileName": "IMI2_Proposal-Template_RIA-IA_en.pdf", "common": false, "crc32": 2865859008}]}, {"callId": 6770, "id": 7763, "title": "IMI2 RIA/IA Evaluation Form", "sectionId": 6770, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 102685, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-02/1635130-imi2_evaluation-form_ria-ia_en.pdf", "id": 1635130, "fileName": "IMI2_Evaluation-Form_RIA-IA_en.pdf", "common": false, "crc32": 2170438193}]}, {"callId": 6770, "id": 7778, "title": "IMI2 Model Grant Agreement", "sectionId": 6770, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 1165682, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-02/1635133-imi_2_mga_2014.07.04_en.pdf", "id": 1635133, "fileName": "IMI_2_MGA_2014.07.04_en.pdf", "common": false, "crc32": 1898683111}]}], "callDetailsJSONItem": {"additionalInfo": "<p>For full information on this call, please refer to the <a href=\"http://www.imi.europa.eu/content/stage-1-14\">Call 3 section of the&nbsp;IMI website.</a></p>\r\n<p>Please note that submitting short proposals for this call can only be done through the <a href=\"https://sofia.imi.europa.eu/Pages/Default.aspx\">IMI SOFIA software tool</a><br />\r\n&nbsp;</p>", "latestInfos": [{"approvalDate": "Mar 9, 2015 2:57:46 PM", "lastChangeDate": "Mar 9, 2015 2:57:18 PM", "content": "<p>Deadline for submission approaching: <span style=\"color: #ff0000\"><strong>24 March 2015 17:00</strong></span> Brussels time</p>\r\n<p><a href=\"http://www.imi.europa.eu/events/2014/12/05/webinars-imi2-calls-3-and-4\">Webinar presentations</a> for all topics now available.</p>"}, {"approvalDate": "Jan 15, 2015 5:56:23 PM", "lastChangeDate": "Jan 15, 2015 5:56:23 PM", "content": "The submission session is now available for: IMI2-2015-03-01(IMI2-RIA-IA), IMI2-2015-03-02(IMI2-RIA-IA), IMI2-2015-03-03(IMI2-RIA-IA), IMI2-2015-03-04(IMI2-RIA-IA), IMI2-2015-03-05(IMI2-RIA-IA), IMI2-2015-03-06(IMI2-RIA-IA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}